TGTX
TG THERAPEUTICS, INC.
+0.45 (+0.81%)56.31USD513K成交股數8.6B市值20.6本益比(近四季)10.8股價營收比+70.3%營收年增(近四季)2026-11-02下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 240M+70% | 205M+70% | 193M+130% | 162M+120% | 141M+122% | 121M+175% | 83.9M-49% | 73.5M+357% | 63.5M | 44.0M | 166M | 16.1M |
| 營業成本 | 41.2M | 33.5M | 38.1M | 28.1M | 18.9M | 15.5M | 9.3M | 8.3M | 5.4M | 7.9M | 3.5M | 1.9M |
| 毛利 | 199M+63% | 171M+63% | 154M+107% | 134M+105% | 122M+111% | 105M+192% | 74.5M-54% | 65.2M+360% | 58.0M | 36.1M | 162M | 14.2M |
| 毛利率 | 82.9% | 83.6% | 80.2% | 82.6% | 86.6% | 87.1% | 88.9% | 88.7% | 91.4% | 82.1% | 97.9% | 88.1% |
| 研發費用 | 95.3M | 48.4M | 41.2M | 40.9M | 31.8M | 46.4M | 20.1M | 17.6M | 32.7M | 17.4M | 14.8M | 28.1M |
| 銷售管理費用 | 82.1M | 88.2M | 62.7M | 63.4M | 55.6M | 50.3M | 42.0M | 38.8M | 34.6M | 31.2M | 32.8M | 30.7M |
| 營業利益 | 21.7M-38% | 34.8M+304% | 50.5M+306% | 29.4M+233% | 34.8M-476% | 8.6M-169% | 12.4M-89% | 8.8M-120% | −9.3M | −12.5M | 115M | −44.7M |
| 營業利益率 | 9.0% | 17.0% | 26.2% | 18.2% | 24.7% | 7.1% | 14.8% | 12.0% | -14.6% | -28.4% | 69.2% | -277.9% |
| 稅後淨利 | 7.8M-72% | 19.8M+291% | 23.1M+494% | 391M+5582% | 28.2M-363% | 5.1M-135% | 3.9M-97% | 6.9M-114% | −10.7M | −14.4M | 114M | −47.6M |
| 淨利率 | 3.2% | 9.7% | 12.0% | 241.7% | 20.0% | 4.2% | 4.6% | 9.4% | -16.9% | -32.7% | 68.7% | -296.2% |
| 稀釋 EPS | 0.05-71% | 0.12+300% | 0.14+600% | 2.43+5975% | 0.17-343% | 0.03-250% | 0.02-97% | 0.04-112% | -0.07 | -0.02 | 0.73 | -0.34 |
| 稀釋股數 | 157M | 160M | 161M | 161M | 163M | 163M | 161M | 159M | 146M | 149M | 156M | 142M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 483M | 442M | 79.1M | 74.1M | 129M | 132M | 196M | 82.9M | 75.5M | 92.9M | 151M | 97.0M |
| 應收帳款 | 402M | 392M | 306M | 265M | 232M | 190M | 116M | 83.6M | 65.0M | 51.1M | 39.3M | 17.5M |
| 存貨 | 148M | 129M | 126M | 147M | 155M | 158M | 84.7M | 81.2M | 77.7M | 39.8M | 33.6M | 30.2M |
| 總資產 | 1.6B | 1.5B | 1.1B | 1.0B | 703M | 657M | 586M | 401M | 373M | 330M | 331M | 221M |
| 有息負債 | 745M | 745M | 246M | 245M | 245M | 245M | 244M | 103M | 101M | 100M | 98.9M | 97.7M |
| 總負債 | 1.0B | 946M | 415M | 418M | 426M | 419M | 394M | 224M | 213M | 169M | 166M | 180M |
| 股東權益 | 604M | 583M | 648M | 607M | 276M | 237M | 192M | 178M | 160M | 161M | 165M | 40.5M |
| 負債比 | 63.2% | 61.9% | 39.1% | 40.8% | 60.7% | 63.9% | 67.2% | 55.7% | 57.1% | 51.3% | 50.2% | 81.7% |
| 淨現金(現金 − 有息負債) | −263M | −303M | −166M | −171M | −116M | −113M | −48.3M | −19.6M | −25.8M | −7.2M | 52.0M | −691K |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −17.9M-38% | – | – | – | −28.7M | – | – | −8.2M | – | – | – |
| 資本支出 | – | 51K | – | – | – | 25K | – | – | 0.00 | – | – | – |
| 自由現金流 | – | −17.9M-38% | – | – | – | −28.7M | – | – | −8.2M | – | – | – |
| 折舊攤銷 | – | 32K | – | – | – | 8K | – | – | 29K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -8.8% | – | – | – | -23.8% | – | – | -12.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 616M
| 產品 | 607M | 98.5% | +93.5% |
|---|---|---|---|
| Royalty | 5.6M | 0.9% | +601.0% |
| Other Revenue | 3.6M | 0.6% | +97.0% |
| License Revenue | 152K | 0.0% | 0.0% |
| License 小計 | 9.4M | 1.5% | -38.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 616M | +87.3% | 447M | 72.6% | 2.77 | −25.0M |
| FY2024 | 329M | +40.8% | 23.4M | 7.1% | 0.15 | −40.6M |
| FY2023 | 234M | +8290.0% | 12.7M | 5.4% | 0.09 | −31.4M |
| FY2022 | 2.8M | -58.4% | −198M | -7,120.3% | -1.65 | −176M |
| FY2021 | 6.7M | +4300.7% | −348M | -5,204.1% | -2.63 | −296M |
| FY2020 | 152K | 0.0% | −279M | -183,803.3% | -2.42 | −215M |
| FY2019 | 152K | 0.0% | −173M | -113,730.9% | -1.96 | −133M |
| FY2018 | 152K | – | −173M | -114,132.9% | -2.30 | −129M |